Clear Skin,
Rewritten
from within.
A twelve-week, application-only acne clarity program with two pathways — topical-only for cutaneous-driven cases, and full gut microbiome repair for systemic involvement. Precision inputs. Clinician oversight. Measurable outcomes.
The same molecule your immune system already uses — engineered for the skin.
Hypochlorous acid (HOCl) is produced inside your neutrophils as the first line of immune defense. Stabilized and formulated at clinical potency, it becomes something very few ingredients can claim to be: broadly antimicrobial, anti-inflammatory, and gentle enough to use every day.
Why HOCl changes the acne conversation.
Conventional acne care forces a trade-off between efficacy and irritation. Benzoyl peroxide, retinoids, and antibiotics work — but at the cost of barrier damage, microbiome disruption, and long-term tolerance issues. EO-100 operates differently.
It disrupts bacterial biofilms, neutralizes C. acnes and other pathogenic organisms, and calms inflammatory signaling at the follicular level — without stripping the skin, without antibiotic resistance, and without compromising the commensal flora that keep skin resilient.
In this protocol, EO-100 is paired with a choreographed sequence of topical activators (Rə'jo͞ov, Rə'act, Rə'stôr) that extend clarity-phase chemistry throughout the day and into the deeper layers of the skin.
Two protocols.
One standard of care.
Every candidate receives the full topical system. Qualifying candidates are invited into the Comprehensive pathway, which treats the gut-skin axis as the upstream driver that it is.
Loading protocols…
Four instruments.
One sequence.
Each component occupies a specific position in the daily and weekly ritual. Together they clarify, calm, and restore the barrier in a single coordinated system.
Prescription-grade stabilized hypochlorous acid (0.01%) dispensed in a glass startup vessel with a fine-mist atomizer. The clinical anchor of the system; used daily and across weekly activations.
A mineral-rich clay activator with embedded HOCl technology. Lifts debris, refines texture, and calms visible redness without the cracking and barrier insult of traditional clay masks. Used 2–3× weekly.
The mid-ritual activator. Re-saturates Rə'jo͞ov during mask wear to re-open its clarity chemistry, and finishes the routine as an all-over mist before the oxygel step.
A barrier-restoring oxygel that seals the sequence. Hydrates, supports the skin's recovery microbiome, and locks in the clarity-phase work without occluding or suffocating the skin.
What the process looks like.
Admission-based, structured, and measurable. Here is exactly how the program unfolds once you are accepted.
Apply & Review
Submit your application and complete the automated clinical intake form. Our clinical team reviews eligibility within 3–5 business days and identifies the appropriate pathway.
Acceptance Interview
Accepted candidates schedule a 30-minute interview with Dr. Lily Woods, PhD — Program Developer & Scientific Director. The interview confirms program fit and orients you to the next 12 weeks.
Prescription & Kits
Our supervising clinician approves the EO-100 prescription. Kits ship to your door — Exclusivité Skin topicals and Factor 14 Labs prescription products together — and your protocol begins.
Protocol & Track
Follow the 12-week protocol guide. A brief automated questionnaire arrives every two weeks. The clinical team intervenes only when something flags — otherwise, you run the protocol uninterrupted.
Outcomes Review
At week 12, a 30-minute completion consultation with Dr. Woods reviews your outcomes, documents before-and-after findings, and plans your maintenance pathway.
Apply for admission.
A brief clinical pre-screening reviewed personally by Dr. Lily Woods, PhD and the clinical team. No payment is collected. Decisions returned within 3–5 business days.
Begin Your Application →Pre-screening only · HIPAA-secure intake · Application is free
Questions, answered.
Still unclear on something? Include it in your application and we'll address it during review.